Warde et al identified risk factors for relapse in a patient with Stage I seminoma managed by surveillance alone. This can help identify which patients may require additional therapy and which can avoid its long term complications. The authors are from the University of Toronto, University of Copenhagen, Aarhus University Hospital, Royal Marsden Hospital (Surrey) and St. Bartholomew's Hospital (London).
